You have no items in your shopping cart.
Human UBE2L6 [orb2993337]Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18.8 KDa. Observed: 17 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Human UBE2V2 [orb2993339]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18.5 KDa. Observed: 18 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human UBE2R2 [orb2993340]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 29.3 KDa. Observed: 37 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human CASP10 [orb2993345]
Unconjugated
SDS-PAGE: Greater than 70% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 30.1 KDa. Observed: 33 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human UBE2B [orb2993355]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.5 KDa. Observed: 18 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human UBE2I [orb2993369]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 44.4 KDa. Observed: 40 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human PRDX4 [orb2993386]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 28.9 KDa. Observed: 30 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human ADPRH [orb2993395]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 41.67 KDa. Observed: 39 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human ATG10 [orb2993400]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 24.5 KDa. Observed: 30 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human UBE2J2 [orb2993401]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37.96 KDa. Observed: 30&36 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg